Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain
Clinical trial NCT07013760 · COMPLETED
Trial details
- NCT number
- NCT07013760
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-06-23
- Primary completion
- 2025-12-19
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.